对 status epilepticus 的二线药物的比较疗效和安全性:一个网络元分析
Qishun Zhang1, Shaokang Peng, Ziyi Wei
1Department of Neurology, Huaihe Hospital of Henan University, Kaifeng, China.
Medicine
|November 19, 2024
概括
芬诺巴比他 (PHB) 显示了状态发作 (SE) 的最高发作控制率. 酸 (VPA) 和 levetiracetam (LEV) 为SE管理提供了明显的优势和值得称赞的安全配置文件.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 状态 (SE) 是一种神经紧急情况,需要迅速有效的治疗.
- 当初始治疗不能终止SE的发作时,二线药物至关重要.
- 需要进行系统审查,以比较可用的二线SE治疗的疗效和安全性.
研究的目的:
- 系统地审查和比较用于状态 (SE) 的二线药物的疗效和安全性.
- 为选择SE的最佳二线治疗提供基于证据的指导.
主要方法:
- 在PubMed,Embase和Cochrane图书馆进行了全面的电子文献搜索.
- 包括到2024年1月发布的二线SE药物的随机对照试验 (RCT).
- 使用R软件进行了网络元分析,合成了23个RCT的数据.
主要成果:
- 费诺巴尔比他 (PHB) 显示出最高的控制率 (98.1%),其次是 levetiracetam (LEV) (60.7%).
- 在有效性方面,PHB排名最高,而氨酸 (VPA) 和 levetiracetam (LEV) 在特定人群中显示出有利的安全性.
- 亚组分析表明PHB在儿科和成人SE中的有效性,VPA在儿童中的优势,LEV在儿童和老年人中的安全性.
结论:
- 类 (PHB) 仍然是SE的高效选择,但其安全性需要仔细监测.
- 瓦尔酸 (VPA) 和 levetiracetam (LEV) 为SE治疗提供了有价值的替代品,具有明显的益处和良好的安全性.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
17.7K
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.0K
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
147
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
147
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
253
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
253
01:14Antiepileptic Drugs: Glutamate Antagonists
284
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
284
01:17Antiepileptic Drugs: Calcium Channel Blockers
323
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
323
01:08Antiepileptic Drugs: Sodium Channel Blockers
430
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
430
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
334
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
334